National manufacturer of
immunobiological products in Russia
En
National manufacturer of
immunobiological products in Russia

Klebsiella purified polyvalent bacteriophage

Trade name

Klebsiella purified polyvalent bacteriophage

Dosage form

Solution for oral, local and external administration.

Shelf life

2 years

Manufacturer

NPO Microgen, 105 Novorossiyskaya str., Ufa, Republic of Bashkortostan, 450014 Russia

Presentation

Solution for oral, local and external administration, 10 ml or 20 ml vials. 4 or 10 vials in each cardboard package with a package insert. 4 vials in each PVC blister. 1 PVC blister in each cardboard package with a package insert.

Ingredients

The preparation is a sterile mixture of purified filtrates of phage lysates of Klebsiella pneumoniae, Klebsiella ozaenae, Klebsiella rhinoscleromatis.

Excipient:
  • preservative – 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (equal to 8-hydroxyquinoline sulfate, estimated content).

Indications

Treatment and prevention of diseases caused by Klebsiella pneumoniae, Klebsiella ozaenae, Klebsiella rhinoscleromatis as part of the complex therapy:
  • atrophic rhinitis, scleroma;
  • disease of the gastrointestinal tract (gastroenterocolitis, cholecystitis, pancreatitis, intestinal disbacteriosis);
  • inflammatory diseases of infants and young children (gastroenterocolitis, intestinal disbacteriosis, omphalitis, pemphigus, pyoderma, septicemia and pyosepticemia of varios localization);
  • surgical infections (festering wounds, purulent skin lesions, burns, peritonitis, pleurisy, mastitis, osteomyelitis, abscess);
  • urogenital infections (cystitis, pyelonephritis, urethritis, endometritis, vulvitis, bartholinitis, colpitis, salpingo-oophoritis);
  • purulent-inflammatory diseases of the ear, nose, sinuses, oral cavity, pharynx, larynx, bronchi, lungs and pleura (otitis, tonsillitis, pharyngitis, laryngitis, stomatitis, periodontal disease, sinusitis, sinusitis, bronchitis, pneumonia, pleurisy);
  • post-traumatic conjunctivitis, keratoconjunctivitis, corneal ulcers and purulent iridocyclitis;
  • prevention of hospital-acquired infections caused by Klebsiella.
An important condition for the effective phage therapy is a preliminary determination of the phage sensitivity of the pathogen.